Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Protagenic Therapeutics Inc | PTIXW | NASDAQ | Equity Warrant |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.0033 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.0033 |
| Trades | Volume | Avg Volume |
|---|---|---|
| 0 | 0 | - |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | 0.0033 | USD |
Protagenic Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 14.64k | 4.44M | - | 0 | -5M | -1.13 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Protagenic Therapeutics
Form PRE 14A - Other preliminary proxy statements Edgar (US Regulatory) •
Thu Feb 27, 2025 9:45 AM (2 weeks ago)
Form 8-K - Current report Edgar (US Regulatory) •
Mon Feb 24, 2025 4:00 PM (2 weeks ago)
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] Edgar (US Regulatory) •
Fri Feb 14, 2025 5:06 PM (4 weeks ago)
Form 8-K - Current report Edgar (US Regulatory) •
Wed Jan 29, 2025 4:01 PM (1 month ago)
Form 8-K - Current report Edgar (US Regulatory) •
Fri Jan 10, 2025 6:04 AM (2 months ago)
Form 424B5 - Prospectus [Rule 424(b)(5)] Edgar (US Regulatory) •
Fri Jan 10, 2025 6:02 AM (2 months ago)
Form EFFECT - Notice of Effectiveness Edgar (US Regulatory) •
Fri Jan 10, 2025 12:15 AM (2 months ago)
Form S-3/A - Registration statement under Securities Act of 1933: [Amend] Edgar (US Regulatory) •
Tue Jan 07, 2025 11:14 AM (2 months ago)
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Edgar (US Regulatory) •
Mon Jan 06, 2025 5:22 PM (2 months ago)
Form DEF 14A - Other definitive proxy statements Edgar (US Regulatory) •
Fri Jan 03, 2025 5:03 PM (2 months ago)
Form 424B3 - Prospectus [Rule 424(b)(3)] Edgar (US Regulatory) •
Fri Dec 27, 2024 4:00 PM (2 months ago)
Form EFFECT - Notice of Effectiveness Edgar (US Regulatory) •
Fri Dec 27, 2024 12:15 AM (3 months ago)
PTIXW Historical
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders. |
NASDAQ:PTIXW -
What is the current Protagenic Therapeutics Inc share price?
The current share price of Protagenic Therapeutics Inc is $ 0.0033
How many Protagenic Therapeutics Inc shares are in issue?
Protagenic Therapeutics Inc has 4,435,000 shares in issue
What is the market cap of Protagenic Therapeutics Inc?
The market capitalisation of Protagenic Therapeutics Inc is USD 14.64k
What is the 1 year trading range for Protagenic Therapeutics Inc share price?
Protagenic Therapeutics Inc has traded in the range of $ 0.00 to $ 0.00 during the past year
What is the PE ratio of Protagenic Therapeutics Inc?
The price to earnings ratio of Protagenic Therapeutics Inc is -0.24
What is the reporting currency for Protagenic Therapeutics Inc?
Protagenic Therapeutics Inc reports financial results in USD
What is the latest annual profit for Protagenic Therapeutics Inc?
The latest annual profit of Protagenic Therapeutics Inc is USD -5M
What is the registered address of Protagenic Therapeutics Inc?
The registered address for Protagenic Therapeutics Inc is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Protagenic Therapeutics Inc website address?
The website address for Protagenic Therapeutics Inc is www.protagenic.com
Which industry sector does Protagenic Therapeutics Inc operate in?
Protagenic Therapeutics Inc operates in the BOOKS: PUBG, PUBG & PRINTING sector
